Financial Diagnosis Report Of HB Pharmaceutical Company

In recent years,with the rapid development of the economy and the aging trend of growth,medical expenditure has been rising,which has strongly promoted the development of the pharmaceutical industry,and the overall scale of the pharmaceutical industry has been expanding.However,with the introduction of new national policies and the entry of new enterprises,new technologies and new products into the market,there will be significant changes in the industry structure,which is both an opportunity and a challenge for enterprises,making the competition in the pharmaceutical industry more intense.In such an environment,HB pharmaceuticals,as an old pharmaceutical company in China,has experienced large profit fluctuations,high costs and poor business performance in recent years.Under such circumstances,it becomes very important to make financial diagnosis of the company and find out the existing problems.In this paper,HB pharmaceutical company is selected as the object of diagnosis.Firstly,the status quo and background of the pharmaceutical industry are introduced.On the basis of current situation of HB pharmaceutical company financial diagnosis,selection of 2016-2018,the company's balance sheet,income statement and statement of cash flows for the structure and trend analysis,and then to the company's debt paying ability,operation ability,profitability and growth ability are analyzed in the longitudinal and transverse analysis,then the analysis based on financial data for the question design questionnaire,analysis of the questionnaire;Therefore,it can be concluded that HB pharmaceutical company has such advantages as outstanding main business,strong receivables management ability,good operation cost control and strong growth ability.Meanwhile,the company also has such problems as high debt paying risk,excessive period expenses,poor inventory management and other excessive receivables.Finally,the paper puts forward corresponding improvement Suggestions from the aspects of improving the solvency,reducing the period cost,strengthening the management of inventory and other revenue revenue in view of the problems existing in HB pharmaceutical company.The purpose of this study is to diagnose the financial situation of HB pharmaceutical company,help the company establish and improve the financial management system,and enhance the company's core competitiveness.